Analyst Price Targets — ATR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 12:03 pm | — | Raymond James | $160.00 | $130.38 | TheFly | AptarGroup price target raised to $160 from $150 at Raymond James |
| February 9, 2026 12:16 pm | — | Robert W. Baird | $156.00 | $134.31 | TheFly | AptarGroup price target raised to $156 from $145 at Baird |
| January 9, 2026 12:58 pm | Paul Knight | KeyBanc | $220.00 | $124.56 | StreetInsider | KeyBanc Reiterates Overweight Rating on AptarGroup (ATR) |
| November 3, 2025 12:18 pm | Ghansham Panjabi | Robert W. Baird | $145.00 | $116.01 | TheFly | AptarGroup price target lowered to $145 from $160 at Baird |
| November 3, 2025 11:05 am | — | Wells Fargo | $133.00 | $116.01 | TheFly | AptarGroup price target lowered to $133 from $152 at Wells Fargo |
| October 28, 2024 6:54 am | Ghansham Panjabi | Robert W. Baird | $185.00 | $169.63 | StreetInsider | AptarGroup (ATR) PT Raised to $185 at Baird |
| October 14, 2024 3:26 am | Daniel Rizzo | Jefferies | $215.00 | $161.55 | StreetInsider | Jefferies Upgrades AptarGroup (ATR) to Buy |
| September 1, 2023 1:48 pm | Thomas Blakey | Loop Capital Markets | $45.00 | $132.55 | Benzinga | Nutanix Set To Outperform With Strong FCF And Hybrid Cloud Focus, Despite Macro Challenges: Analyst |
| August 2, 2022 8:22 am | — | Morgan Stanley | $120.00 | $108.20 | Benzinga | Morgan Stanley Maintains Equal-Weight on AptarGroup, Lowers Price Target to $120 |
| August 1, 2022 9:57 am | — | Robert W. Baird | $110.00 | $108.06 | Benzinga | Baird Maintains Neutral on AptarGroup, Lowers Price Target to $110 |
Latest News for ATR
Patient-level matched analysis of real-world data demonstrated a significant 37% relative reduction in severe bleeding Significant reductions in 24-hour chest tube drainage and red blood cell transfusions were also seen, with no serious device-related adverse events reported Findings reinforce results from the STAR-T trial and are expected to form a core component of additional real-world evidence planned for a new…
Callan Family Office LLC acquired a new stake in AptarGroup, Inc. (NYSE: ATR) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,429 shares of the industrial products company's stock, valued at approximately $1,181,000. A number of other
Deutsche Bank AG bought a new stake in AptarGroup, Inc. (NYSE: ATR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 119,035 shares of the industrial products company's stock, valued at approximately $14,903,000. Deutsche Bank AG owned approximately 0.19% of
Aurora Investment Counsel acquired a new stake in shares of AptarGroup, Inc. (NYSE: ATR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 11,785 shares of the industrial products company's stock, valued at approximately $1,475,000. Other hedge funds have
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ATR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.